Every rating change, initiation and price-target move the sell side published across the equities tracked here, newest first.
Ratings are attributed to the research firm, not to individual analysts. Latest event 2d ago.
| Ticker | Firm | Action | Rating | Target | Date |
|---|---|---|---|---|---|
| LQDALiquidia Corporation | LifeSci Capital | Upgraded from Market Perform | Outperform | $59 | Oct 14 |
| OBXObsidian Therapeutics, Inc. | LifeSci Capital | Initiated | Outperform | $43 | Aug 18 |
| LQDALiquidia Corporation | LifeSci Capital |
Showing the 3 most recent actions over 90 days.
| Downgraded from Outperform |
| Market Perform |
| $90 |
| Aug 12 |